Results from the CARTITUDE-2 trial VJHemOnc – Video Journal of Hematology & HemOnc 2:28 3 years ago 110 Далее Скачать
CARTITUDE-2 trial update and management of neurotoxicities VJHemOnc – Video Journal of Hematology & HemOnc 4:40 3 years ago 43 Далее Скачать
CARTITUDE-2: evaluating CAR T therapy Cilta-Cel in multiple myeloma patients who had early relapse International Myeloma Foundation 5:03 2 years ago 347 Далее Скачать
ASH23: CARTITUDE-2 Trial on Ciltacabtagene Autoleucel in Multiple Myeloma | Jens Hillengass, MD, PhD International Myeloma Foundation 6:54 11 months ago 245 Далее Скачать
An update on cohort C from the CARTITUDE-2 trial VJHemOnc – Video Journal of Hematology & HemOnc 2:01 2 years ago 181 Далее Скачать
Latest results from the CARTITUDE-2 trial of cilta-cel in progressive multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:33 3 years ago 120 Далее Скачать
CARTITUDE-2: Efficacy and safety of ciltacabtagene autoleucel in patients with progressive MM International Myeloma Foundation 7:23 3 years ago 392 Далее Скачать
CARTITUDE-2: Ciltacabtagene autoleucel in patients with progressive multiple myeloma ecancer 7:41 3 years ago 99 Далее Скачать
Interim results of the ProMMise trial: belantamab + cyclophosphamide & dexamethasone in R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:53 2 days ago 33 Далее Скачать
An update on CARTITUDE-2: cilta-cel in patients with multiple myeloma in second line VJHemOnc – Video Journal of Hematology & HemOnc 1:21 2 years ago 96 Далее Скачать
CARTITUDE-2 update: cilta-cel in relapsed and lenalidomide-refractory patients with multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:45 2 years ago 63 Далее Скачать
Updated Data from CARTITUDE-1 and CARTITUDE-2 Studies Testing Cilta-Cel in R/R Multiple Myeloma CheckRare 3:37 1 year ago 386 Далее Скачать
Updates on Clinical Data of Cilta-Cel in CARTITUDE-2 Cohort A among Progressive MM patients International Myeloma Foundation 8:45 2 years ago 208 Далее Скачать
Latest Results from the CARTITUDE-2 Study Testing Cilta-cel in Multiple Myeloma Patients CheckRare 5:34 2 years ago 200 Далее Скачать
Are there trials evaluating CAR T-cell therapy in early disease myeloma patients? International Myeloma Foundation 4:09 2 years ago 957 Далее Скачать
Updated Results (2 years post-LPI) in Phase 1b/2 (CARTITUDE-1) Study of Cilta-Cel in RRMM patients International Myeloma Foundation 3:52 2 years ago 427 Далее Скачать
Cilta-cel in lenalidomide-refractory MM patients: updates from cohort A of the CARTITUDE-2 trial VJHemOnc – Video Journal of Hematology & HemOnc 3:07 2 years ago 193 Далее Скачать
Exciting CAR-T data in multiple myeloma and follicular lymphoma: CARTITUDE-2, ELARA & ZUMA-5 VJHemOnc – Video Journal of Hematology & HemOnc 1:10 2 years ago 78 Далее Скачать
Safety and Efficacy of Cilta Cel: CARTITUDE-2 Study | Jens Hillengass, MD, PhD | ASH 2023 HealthTree Foundation for Multiple Myeloma 3:43 11 months ago 158 Далее Скачать
Results from CARTITUDE-4: cilta-cel for lenalidomide-refractory multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 8:16 1 year ago 434 Далее Скачать
